Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Sunsho Pharmaceutical Co., Ltd. has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed among 4 distinct examiners and 4 distinct art units, giving each matter a separate examination assignment in the record.
DEKARSKE, MADELINE MCGUIRE is the busiest examiner, with 1 pending matter. Counsel should maintain four examiner-specific prosecution tracks and avoid assuming that developments in one matter will carry across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (50%) |
| §103 only | 1 (25%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEKARSKE, MADELINE MCGUIRE | 1 | 20.0% | +50.0% |
| IVANOVA, SVETLANA M | 1 | 50.9% | +51.8% |
| GULLEDGE, BRIAN M | 1 | 55.9% | +26.2% |
| RAMOS LEWIS, JOSMALEN MILAGROS | 1 | 55.1% | +28.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691644 | CARYOPHYLLENE-CONTAINING COMPOSITION | DEKARSKE, MADELINE MCGUIRE | — |
| 17910672 | CARYOPHYLLENE-CONTAINING AGENT OR COMPOSITION AND VARIOUS APPLICATIONS THEREOF | GULLEDGE, BRIAN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691644 | CARYOPHYLLENE-CONTAINING COMPOSITION | DEKARSKE, MADELINE MCGUIRE | — |
| 18250599 | COMPOSITION FOR TREATING VASCULAR DISEASE, COMPOSITION FOR PREVENTING VASCULAR DISEASE, COMPOSITION FOR TREATING HYPERTENSION, AND COMPOSITION FOR PREVENTING HYPERTENSION | IVANOVA, SVETLANA M | — |
| 17910672 | CARYOPHYLLENE-CONTAINING AGENT OR COMPOSITION AND VARIOUS APPLICATIONS THEREOF | GULLEDGE, BRIAN M | — |
| 17270609 | COMPOSITION CONTAINING PLASMALOGEN FOR ENHANCING MEMORIZATION ABILITY | RAMOS LEWIS, JOSMALEN MILAGROS | — |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| 1627 | 1 |
| 1699 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691644 | CARYOPHYLLENE-CONTAINING COMPOSITION | DEKARSKE, MADELINE MCGUIRE | 1622 | §101§102§103DP | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18250599 | COMPOSITION FOR TREATING VASCULAR DISEASE, COMPOSITION FOR PREVENTING VASCULAR DISEASE, COMPOSITION FOR TREATING HYPERTENSION, AND COMPOSITION FOR PREVENTING HYPERTENSION | IVANOVA, SVETLANA M | 1627 | Other | Final Rejection | — | Pending | Apr 26, 2023 |
| 17910672 | CARYOPHYLLENE-CONTAINING AGENT OR COMPOSITION AND VARIOUS APPLICATIONS THEREOF | GULLEDGE, BRIAN M | 1699 | §101§103Other | Final Rejection | — | Pending | Sep 09, 2022 |
| 17270609 | COMPOSITION CONTAINING PLASMALOGEN FOR ENHANCING MEMORIZATION ABILITY | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | §103 | Final Rejection | — | Pending | Feb 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSunsho Pharmaceutical Co., Ltd. has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Madeline Mcguire Dekarske has the most, with 1 of Sunsho Pharmaceutical Co., Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
